Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMC2 pseudogene 1 (PSMC2P1) is a pseudogene related to the gene encoding the proteasome 26S subunit, ATPase 2 (PSMC2), which is a core component of the 26S proteasome complex involved in regulated protein degradation. Pseudogenes such as PSMC2P1 do not code for functional proteins and generally lack direct biological or therapeutic relevance. There is no evidence that PSMC2P1 has any known molecular function, involvement in cellular pathways, or role in human disease. It is not considered a receptor, enzyme, transporter, or any classical druggable target and has not been implicated as a biomarker or target for drugs or experimental therapeutics. Searches for biological function, clinical relevance, and drug interaction yield no substantive information, indicating this entry exists mainly for genomic annotation purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PSMC2 pseudogene 1 (PSMC2P1).